These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7201400)

  • 1. Behavioural and biochemical changes following chronic administration of L-dopa to rats.
    Pycock C; Dawbarn D; O'Shaughnessy C
    Eur J Pharmacol; 1982 Apr; 79(3-4):201-15. PubMed ID: 7201400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
    Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate.
    Barnes JC; Barnes NJ; Barnes NM; Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1987 Jul; 26(7A):693-700. PubMed ID: 3114665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
    Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM
    Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy.
    Wilner KD; Butler IJ; Seifert WE; Clement-Cormier YC
    Biochem Pharmacol; 1980 Mar; 29(5):701-6. PubMed ID: 20227943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
    J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Superata J
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):101-12. PubMed ID: 1977408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor changes during chronic dopaminergic stimulation.
    Jenner P; Boyce S; Marsden CD
    J Neural Transm Suppl; 1988; 27():161-75. PubMed ID: 2900291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A; Ceresoli G; Mandelli V; Parenti M
    J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
    Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
    Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor.
    Kerkman DJ; Ackerman M; Artman LD; MacKenzie RG; Johnson MC; Bednarz L; Montana W; Asin KE; Stampfli H; Kebabian JW
    Eur J Pharmacol; 1989 Aug; 166(3):481-91. PubMed ID: 2509217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antagonism between L-DOPA and apomorphine in their effects on rat behavior].
    Allikmets LKh; Zharkovskiĭ Am; Vasar EE
    Biull Eksp Biol Med; 1977 Jul; 84(7):51-3. PubMed ID: 560890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease.
    Nakazato T; Akiyama A
    Brain Res; 2002 Mar; 930(1-2):134-42. PubMed ID: 11879803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered behavioural and neurochemical profile of L-DOPA following deuterium substitutions in the molecule.
    Malmlöf T; Svensson TH; Schilström B
    Exp Neurol; 2008 Aug; 212(2):538-42. PubMed ID: 18561915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.
    Jackson DM; Jenkins OF; Malor R; Christie MJ; Gregory P
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):271-4. PubMed ID: 6686648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.